Kazuma Sekiba, MD, PhD

Postdoctoral Scholar, Pathology

Honors & Awards

Basic Research Award, The 2023 Stanford Pathology Research Retreat (Nov. 2023)
Basic Research Award, The 2022 Stanford Pathology Research Retreat (Nov. 2022)
Early Career Investigator Award in Basic Science, American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2019 (Nov. 2019)
Gilead Sciences Award, Japanese Society of Hepatology (Nov. 2019)
Basic Science Travel Award, Digestive Disease Week (DDW) 2019 (May 2019)
Early Career Investigator Award in Basic Science, American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2018 (Nov. 2018)
Poster Award, Falk Symposium 212 (Sep. 2018)

Professional Education

Doctor of Philosophy, University Of Tokyo (2020)
Doctor of Medicine, Yokohama City University (2011)
Board Certification, Japan Society of Hepatology, Hepatology (2019)
Board Certification, Japan Gastroenterological Endoscopy Society, Gastroenterological Endoscopy (2018)
Board Certification, Japanese Board of Cancer Therapy, Oncology (2017)
Board Certification, Japanese Society of Gastroenterology, Gastroenterology (2017)

All Publications

Profiles With Related Publications

close
Anais Amaya

Postdoctoral Scholar, Stem Cell Transplantation

14 Total Publications
close
Patrick O. Brown

Professor of Biochemistry, Emeritus
Research Interests
Dr. Brown, currently an emeritus professor, is founder of Impossible Foods, a company dedicated to replacing the world's most destructive technology - the use of animals to transform plant biomass into meat, fish and dairy foods - by developing a new and better way to produce the world's most delicious, nutritious and affordable meats, fish and dairy foods directly from plants. Visit impossiblefoods.com for more information. He is also founder and president of the Impossible Foundation.

319 Total Publications
close
Le Cong

Assistant Professor of Pathology (Pathology Research) and of Genetics
Research Interests
Our lab are developing gene-editing technologies, such as CRISPR systems for in vivo therapy, and cleavage-free techniques for large gene insertion via microbial recombinase. Our team also pioneers in single-cell tracking for cancer and immunology studies using novel CRISPR tools. To accelerate our work, we integrate AI and machine learning into these technologies, design and evolve proteins/RNAs, pushing frontiers in understanding and treating neurological and immunological disease.

39 Total Publications
close
Christopher H. Contag

Professor of Pediatrics (Neonatology), Emeritus
Research Interests
We develop and use the tools of molecular imaging to understand oncogenesis, reveal patterns of cell migration in immunosurveillance, monitor gene expression, visualize stem cell biology, and assess the distribution of pathogens in living animal models of human biology and disease. Biology doesn't occur in "a vacuum" or on coated plates--it occurs in the living body and that's were we look for biological patterns and responses to insult.

355 Total Publications
close
Renumathy Dhanasekaran

Assistant Professor of Medicine (Gastroenterology)
Clinical Focus
Liver cancer, Liver translant, Hepatology, Gastroenterology
Research Interests
The overall goal of my research is to understand the molecular pathogenesis of liver cancer and identify biologically relevant prognostic biomarkers and molecular targets for therapy in patients with hepatocellular carcinoma (HCC). My long-term objective is to improve the clinical outcome of patients with liver cancer.

173 Total Publications
close
Dean W. Felsher

Professor of Medicine (Oncology) and of Pathology
Research Interests
My laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.

217 Total Publications
close
Gabriel Garcia, MD

Professor of Medicine (Gastroenterology and Hepatology) at the Stanford University Medical Center, Emeritus
Research Interests
The natural history of common viral liver diseases of man is poorly understood, despite the fact that chronic liver diseases of man may result in death from liver failure or hepatocellular carcinoma.

48 Total Publications
close
Anson Lowe

Associate Professor of Medicine (Gastroenterology and Hepatology), Emeritus
Research Interests
The laboratory is focused on the relationship between injury, wound healing, and cancer. Esophageal, gastric, and pancreatic cancers are a focus. We are particularly interested in the regulation of cell signaling by EGFR, the EGF receptor. In addition to cancer pathogenesis, active projects include the development of new diagnostic assays and drugs.

52 Total Publications
close
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health
Clinical Focus
Liver cancer and tumors, Hepatocellular Carcinoma, Cirrhosis, Non-alcoholic fatty liver disease, Chronic hepatitis B and C, Hepatology and Liver Transplantation, End-stage liver disease, Evaluation of abnormal liver tests, Community Outreach, Liver tumors, Transplant Hepatology
Research Interests
We conduct clinical trials and epidemiological, translational, and real-world studies of liver cancer, fatty liver (NASH, NAFLD), viral hepatitis B and C, liver cirrhosis, and liver transplant. We focus on risk identification for disease prevention and treatment for improvement of survival. We focus on sex, racial/ethnic, and socioeconomic disparities. We specialize in clinical trials, large international real-world consortium registry data, and large public/semi-public databases.

816 Total Publications
close
Garry Nolan

Rachford and Carlota Harris Professor
Research Interests
Dr. Nolan's group uses high throughput single cell analysis technology cellular biochemistry to study autoimmunity, cancer, virology (influenza & Ebola), as well as understanding normal immune system function. Using advanced flow cytometric techniques such as Mass Cytometry, MIBI (ion beam imaging), CODEX and computational biology approaches, we focus on understanding disease processes at the single cell level. We have a strong interest in cancer immunotherapy and pathogen-host interactions.

466 Total Publications
close
Jonathan Pollack

Professor of Pathology
Research Interests
Research in the Pollack lab centers on translational genomics, with a focus on human cancer. The lab employs next-generation sequencing, single-cell genomics, genome editing, and cell/tissue-based modeling to uncover disease mechanisms, biomarkers and therapeutic targets. Current areas of emphasis include diseases of the prostate (prostate cancer and benign prostatic hyperplasia), as well as odontogenic neoplasms.

115 Total Publications
close
Nathan Reticker-Flynn, PhD

Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Research Interests
To metastasize throughout our bodies, tumors subvert and co-opt our immune systems. Our lab seeks to uncover how these processes occur and develops therapies to put a stop to them.

24 Total Publications